Epilepsy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Epilepsy stocks.

Recent Signals

Date Stock Signal Type
2021-03-05 AQST Hammer Candlestick Bullish
2021-03-05 AQST Lizard Bullish Bullish Day Trade Setup
2021-03-05 AQST Lower Bollinger Band Walk Weakness
2021-03-05 CCM Expansion Pivot Sell Setup Bearish Swing Setup
2021-03-05 CCM Fell Below 50 DMA Bearish
2021-03-05 CCM Wide Range Bar Range Expansion
2021-03-05 CERE Doji - Bullish? Reversal
2021-03-05 CPRX Lower Bollinger Band Walk Weakness
2021-03-05 CPRX Lizard Bullish Bullish Day Trade Setup
2021-03-05 CPRX Hammer Candlestick Bullish
2021-03-05 IGC 1,2,3 Pullback Bullish Bullish Swing Setup
2021-03-05 IGC Hammer Candlestick Bullish
2021-03-05 IGC Stochastic Buy Signal Bullish
2021-03-05 LCI Hammer Candlestick Bullish
2021-03-05 LCI Lizard Bullish Bullish Day Trade Setup
2021-03-05 LCI MACD Bullish Signal Line Cross Bullish
2021-03-05 MJ Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 MJ 50 DMA Support Bullish
2021-03-05 MJ Lizard Bullish Bullish Day Trade Setup
2021-03-05 MJ Doji - Bullish? Reversal
2021-03-05 MJ Hammer Candlestick Bullish
2021-03-05 NBIX Pocket Pivot Bullish Swing Setup
2021-03-05 NBIX Lower Bollinger Band Walk Weakness
2021-03-05 NTUS Hammer Candlestick Bullish
2021-03-05 NTUS Doji - Bullish? Reversal
2021-03-05 NTUS Lizard Bullish Bullish Day Trade Setup
2021-03-05 NTUS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 NTUS 50 DMA Support Bullish
2021-03-05 OVID Calm After Storm Range Contraction
2021-03-05 PRAX Slingshot Bearish Bearish Swing Setup
2021-03-05 PRAX Lower Bollinger Band Walk Weakness
2021-03-05 SUPN 200 DMA Support Bullish
2021-03-05 SUPN Lower Bollinger Band Walk Weakness
2021-03-05 ZYNE Hammer Candlestick Bullish
2021-03-05 ZYNE Lizard Bullish Bullish Day Trade Setup
2021-03-05 ZYNE MACD Bearish Centerline Cross Bearish
2021-03-05 ZYNE Crossed Above 200 DMA Bullish
2021-03-05 ZYNE Doji - Bullish? Reversal

Recent News for Epilepsy Stocks

Date Stock Title
Mar 6 AQST ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – AQST
Mar 6 AQST The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Mar 5 ZYNE Zynerba Pharmaceuticals (ZYNE) Gains But Lags Market: What You Should Know
Mar 5 AQST SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Mar 5 AQST SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc.– AQST
Mar 5 AQST INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Aquestive Therapeutics, Inc. (AQST) Investors
Mar 5 GWPH Why GW Pharmaceuticals Stock Rocketed 40.5% in February
Mar 5 GWPH Driven By Stem Is A DaaS Platform Designed For The Future Of The Cannabis Industry
Mar 5 AQST Aquestive Therapeutics to Host Investor & Analyst Virtual Epinephrine Drug Delivery R&D Event on March 25 at 9:00 a.m. ET
Mar 4 AQST INVESTOR DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Mar 4 MJ Cannabis ETFs are among today's top decliners
Mar 4 AQST SHAREHOLDER ALERT: Robbins LLP Announces That Aquestive Therapeutics, Inc. (AQST) is Being Sued for Misleading Shareholders
Mar 4 AQST GLOBAL INVESTOR RIGHTS LAW FIRM, ROSEN, Encourages Aquestive Therapeutics, Inc. Investors with LARGE LOSSES to Secure Qualified Counsel Before Important Deadline - AQST
Mar 4 AQST The Law Offices of Frank R. Cruz Announces Investigation of Aquestive Therapeutics, Inc. (AQST) on Behalf of Investors
Mar 4 AQST AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm
Mar 4 CPRX Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 16th, 2021
Mar 4 AQST AQUESTIVE THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP notifies investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey
Mar 4 AQST SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Mar 4 AQST Notice of Lead Plaintiff Deadline for Shareholders in the Aquestive Therapeutics, Inc. Class Action Lawsuit
Mar 4 ZYNE Zynerba Pharmaceuticals to Participate in the 33rd Annual ROTH Conference

Epilepsy is a group of neurological disorders characterized by epileptic seizures. Epileptic seizures are episodes that can vary from brief and nearly undetectable periods to long periods of vigorous shaking. These episodes can result in physical injuries, including occasionally broken bones. In epilepsy, seizures tend to recur and, as a rule, have no immediate underlying cause. Isolated seizures that are provoked by a specific cause such as poisoning are not deemed to represent epilepsy. People with epilepsy may be treated differently in various areas of the world and experience varying degrees of social stigma due to their condition.The cause of most cases of epilepsy is unknown. Some cases occur as the result of brain injury, stroke, brain tumors, infections of the brain, and birth defects through a process known as epileptogenesis. Known genetic mutations are directly linked to a small proportion of cases. Epileptic seizures are the result of excessive and abnormal neuronal activity in the cortex of the brain. The diagnosis involves ruling out other conditions that might cause similar symptoms, such as fainting, and determining if another cause of seizures is present, such as alcohol withdrawal or electrolyte problems. This may be partly done by imaging the brain and performing blood tests. Epilepsy can often be confirmed with an electroencephalogram (EEG), but a normal test does not rule out the condition.Epilepsy that occurs as a result of other issues may be preventable. Seizures are controllable with medication in about 70% of cases. Inexpensive options are often available. In those whose seizures do not respond to medication, surgery, neurostimulation or dietary changes may then be considered. Not all cases of epilepsy are lifelong, and many people improve to the point that treatment is no longer needed.As of 2015, about 39 million people have epilepsy. Nearly 80% of cases occur in the developing world. In 2015, it resulted in 125,000 deaths up from 112,000 deaths in 1990. Epilepsy is more common in older people. In the developed world, onset of new cases occurs most frequently in babies and the elderly. In the developing world, onset is more common in older children and young adults, due to differences in the frequency of the underlying causes. About 5–10% of people will have an unprovoked seizure by the age of 80, and the chance of experiencing a second seizure is between 40 and 50%. In many areas of the world, those with epilepsy either have restrictions placed on their ability to drive or are not permitted to drive until they are free of seizures for a specific length of time. The word epilepsy is from Ancient Greek ἐπιλαμβάνειν, "to seize, possess, or afflict".

More about Epilepsy
Browse All Tags